These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR. Schmidt P; Thiele M; Rudroff C; Vaz A; Schilli M; Friedrich K; Scheele J Hepatogastroenterology; 2001; 48(42):1675-9. PubMed ID: 11813599 [TBL] [Abstract][Full Text] [Related]
23. Subunit composition, regulatory properties, and phosphorylation of phosphofructokinase from human gliomas. Staal GE; Kalff A; Heesbeen EC; van Veelen CW; Rijksen G Cancer Res; 1987 Oct; 47(19):5047-51. PubMed ID: 2957049 [TBL] [Abstract][Full Text] [Related]
24. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases. Chen C; Chen LQ; Yang GL; Li Y Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322 [TBL] [Abstract][Full Text] [Related]
25. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93. Shitara K; Hanai N; Yoshida H Cancer Res; 1987 Mar; 47(5):1267-72. PubMed ID: 3545444 [TBL] [Abstract][Full Text] [Related]
26. Targeting of the catalytic subunit of protein phosphatase-1 to the glycolytic enzyme phosphofructokinase. Zhao S; Lee EY Biochemistry; 1997 Jul; 36(27):8318-24. PubMed ID: 9204878 [TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer. Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917 [TBL] [Abstract][Full Text] [Related]
28. Phosphofructokinase of calf trabecular meshwork. Anderson PJ; Karageuzian LN; Epstein DL Invest Ophthalmol Vis Sci; 1984 Nov; 25(11):1262-6. PubMed ID: 6238014 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9. Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158 [TBL] [Abstract][Full Text] [Related]
30. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer. Buccheri G; Ferrigno D J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793 [TBL] [Abstract][Full Text] [Related]
31. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers. Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219 [TBL] [Abstract][Full Text] [Related]
32. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125 [TBL] [Abstract][Full Text] [Related]
33. Nonspecific cross-reacting antigen-50/90 (NCA-50/90) as a new tumor marker. Kuroki M; Matsushita H; Matsumoto H; Hirose Y; Senba T; Yamamoto T Anticancer Res; 1999; 19(6C):5599-606. PubMed ID: 10697625 [TBL] [Abstract][Full Text] [Related]
34. Measurement of ferritin-bearing peripheral mononuclear blood cells in cancer patients by radioimmunoassay. Bluestein BI; Luderer AA; Hess D; Smith D; Meyer KK; Boyle G; Carter AC Cancer Res; 1984 Sep; 44(9):4131-6. PubMed ID: 6744324 [TBL] [Abstract][Full Text] [Related]
35. [Clinical usefulness of phosphofructokinase(PFK)-inhibition test as a tumor marker in the patients with solid tumor]. Ogiwara H; Nara K; Takami H; Abe O; Nakamura K Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):966-76. PubMed ID: 2961830 [No Abstract] [Full Text] [Related]
36. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer. Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811 [TBL] [Abstract][Full Text] [Related]
37. Detection of patients with cancer by monoclonal antibody directed to lactoneotetraosylceramide (paragloboside). Myoga A; Taki T; Arai K; Sekiguchi K; Ikeda I; Kurata K; Matsumoto M Cancer Res; 1988 Mar; 48(6):1512-6. PubMed ID: 3345524 [TBL] [Abstract][Full Text] [Related]
38. Detection of antigen-specific immune complexes in sera of gastric and esophageal cancer patients. Li G; Zhang XY; Fan DM; Hu JL Chin Med J (Engl); 1994 Mar; 107(3):189-91. PubMed ID: 7522142 [TBL] [Abstract][Full Text] [Related]
39. Fructose-2,6-bisphosphate counteracts guanidinium chloride-, thermal-, and ATP-induced dissociation of skeletal muscle key glycolytic enzyme 6-phosphofructo-1-kinase: A structural mechanism for PFK allosteric regulation. Zancan P; Almeida FV; Faber-Barata J; Dellias JM; Sola-Penna M Arch Biochem Biophys; 2007 Nov; 467(2):275-82. PubMed ID: 17923106 [TBL] [Abstract][Full Text] [Related]
40. A protein inhibitor of phosphofructokinase from the mucosa of rat small intestine. A mechanism for the regulation of glycolysis that is independent of glucose. Kellett GL; Robertson JP Biochem J; 1984 Jun; 220(2):601-4. PubMed ID: 6234889 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]